Sign In
Buy TAK
$15.03
-0.150 (-0.99%)
At Close: Jun 03, 2026
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced financial results for fiscal year 2020 (period ended March 31, 2021). TAKEDA
Moving Average Crossover Alert: Takeda Pharmaceutical (TAK)
07:31am, Monday, 03'rd May 2021
Takeda Pharmaceutical (TAK) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Takeda: A Rare Biopharma Bargain
05:22am, Sunday, 02'nd May 2021
Takeda is one of the top ten biopharma companies worldwide in terms of revenue, and the number one in Asia.
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has granted
Down Nearly 50% From All-Time Highs, Is This Pharma Giant a Good Buy?
06:28am, Saturday, 24'th Apr 2021
You might want to consider adding this company to your portfolio.
Coursera, Lattice Semiconductors, Qualcomm and More Monday Afternoon Analyst Calls
12:05pm, Monday, 19'th Apr 2021
With the trading day about halfway over, the broad markets were pulling back after setting record highs to close out last week.
Larry Robbins' Firm Jumps Into Longview Acquisition Corp
04:20pm, Monday, 05'th Apr 2021
Larry Robbins ( Trades , Portfolio )'s firm has revealed a new buy into Longview Acquisition Corp. II (NYSE:LGV.U) according to GuruFocus' Real-Time Picks, a Premium feature.
Why Molecular Templates Stock Crashed Today
04:12pm, Monday, 05'th Apr 2021
The company is taking back rights to one drug candidate and discontinuing development of another.
ARK Genomic Revolution Multi-Sector ETF: Poised For Continued Underperformance
07:27am, Friday, 02'nd Apr 2021
ARK Genomic Revolution Multi-Sector ETF: Poised For Continued Underperformance
Takeda Hosts Wave 1 Pipeline Market Call
10:18am, Thursday, 01'st Apr 2021
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will host a conference call on April 6, 2021 to provi
Takeda: Why Now Is The Time For Taking The Opportunity For Getting On The Takeda A-Train
01:12am, Thursday, 01'st Apr 2021
Takeda: Why Now Is The Time For Taking The Opportunity For Getting On The Takeda A-Train
Takeda Is A Mediocre Income Investment
11:37am, Wednesday, 31'st Mar 2021
Takeda is a Japanese healthcare company that pays consistent dividends. The company is trying to achieve growth using acquisition and research, and so far fails.
Takeda Completes Sale of Its Japan Consumer Health Care Business Unit to Blackstone
02:00am, Wednesday, 31'st Mar 2021
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of Takeda Consumer Healthcar
Takeda, BridGene To Pursue Undruggable Neurodegenerative Targets
01:56pm, Tuesday, 30'th Mar 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) has teamed up with BridGene Biosciences to discover small molecules against hard-to-drug therapeutic targets. The deal will utilize BridGene's IMTAC Chem
Alibaba, Amazon, Palantir, Google, Takeda, Unity — What Cathie Wood's Ark Bought And Sold On Thursday
12:59am, Friday, 26'th Mar 2021
Cathie Wood's Ark Investment Management sends out an email every night listing the stocks that were bought or sold by the firm's ETFs that day. In recent months, the emails have known to cause certain
